Dow Jones Newswires: Ipsen to acquire U.S.-based Epizyme for $247 million.
The primary focus of the acquisition is the lead medicine, Tazverik, which was granted FDA accelerated approval in 2020
Dow Jones Newswires: AstraZeneca Enhertu breast cancer drug is recommended for EU approval
The decision was based on trial results showing that Enhertu cut the risk of disease progression or death by 72% compared with the trastuzumab emtansine...
The Moneyist: ‘She has a poor work ethic’: I rent out rooms in a single-family home. I charge $1,300 per room, but my sister only pays $800. Should I ask her to pay more?
‘She is 33 years old, does not have a track record of holding down a steady job, and pays rent late in the month.’
Next Avenue: Don’t trust everything you buy on the internet: The ugly truth about online pharmacies
Buying prescription meds from fraudulent online pharmacies can jeopardize your health and compromise your financial and personal data.
Kelley Blue Book: Will the 4th of July weekend be a good time to buy a car?
Fourth of July weekend is usually a good time to get a discount on a car, but this year, not so much. Here are some...
NerdWallet: A strong U.S. dollar abroad can take some of the sting off rising travel costs
One small bright spot among the bleak outlook for summer travel costs: The U.S. dollar is especially strong against many foreign currencies.
Kelley Blue Book: This is the cheapest electric car, and it just got an update
There's lots of exciting new options in the EV market, but this veteran still gets the job done at the right price.
NerdWallet: Inflation is hitting small businesses hardest in these cities and states
Small-business owners are also dealing with higher prices and supply chain problems. Here's where they're feeling it the most.
Market Snapshot: U.S. stock futures point to further Wall Street gains on view bad news is good news
U.S. stock futures pointed to an extension of last week's gains, buoyed by data showing a slowing economy that in turn could limit the magnitude...